CD40 and neoplasm: Here, we report that the main response to agonostic CD40 mAb therapy in murine melanoma tumor endothelial cells is not due to engagement of CD40 on endothelial cells, but secondary to IFNγ-secretion by activated cytotoxic T-cells.